KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Accounts Payables: 2018-2025

Historic Accounts Payables for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to $11.1 million.

  • Twist Bioscience's Accounts Payables rose 580.61% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.1 million, marking a year-over-year increase of 580.61%. This contributed to the annual value of $11.1 million for FY2025, which is 580.61% up from last year.
  • Latest data reveals that Twist Bioscience reported Accounts Payables of $11.1 million as of FY2025, which was up 580.61% from $1.6 million recorded in FY2024.
  • In the past 5 years, Twist Bioscience's Accounts Payables registered a high of $20.1 million during FY2022, and its lowest value of $1.6 million during FY2024.
  • Its 2-year average for Accounts Payables is $6.4 million, with a median of $6.4 million in 2024.
  • Data for Twist Bioscience's Accounts Payables shows a peak YoY soared of 580.61% (in 2025) over the last 5 years.
  • Yearly analysis of 4 years shows Twist Bioscience's Accounts Payables stood at $14.9 million in 2021, then skyrocketed by 34.85% to $20.1 million in 2022, then reached $1.6 million in 2024, then spiked by 580.61% to $11.1 million in 2025.